BGI China
China's top gene-sequencing provider BGI will participate in the Genome Program, which aims to use genomic data to improve health outcomes in the United Arab Emirates (UAE), the company announced Wednesday.
The program plans to use large-scale genomic data to establish a health care system with predictable, preventative and individual-based medical treatment for the UAE people, according to the Shenzhen-based company.